insights_auto
Why is EVGN up 2.77%?
Dive Deeperchevron_right
EVGN:NASDAQ
Evogene Ltd
$0.37
arrow_upward
+2.77%(+0.0100) 1D
Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EVGN...
Open
$0.37
High
$0.39
Low
$0.35
Mkt. cap
6.72M
Avg. vol.
444.59K
Volume
62.59K
52-wk high
$1.26
52-wk low
$0.25
EPS
-$0.90
Beta
1.45
Shares outstanding
18.05M
No. of employees
52
Open
$0.37
High
$0.39
Low
$0.35
Mkt. cap
6.72M
Avg. vol.
444.59K
Volume
62.59K
52-wk high
$1.26
52-wk low
$0.25
EPS
-$0.90
Beta
1.45
Shares outstanding
18.05M
No. of employees
52
News stories
From web sources and news partners
qz.com
·
7 hours ago
How much of the S&P 500 is Nvidia? Concentration explained
marketscreener.com
·
7 hours ago
S&P 500 Posts Weekly Gain as Energy Sector Leads Broad Climb
TradingView
·
5 hours ago
S&P 500, Dow, Nasdaq End Lower Amid Nvidia Turmoil, But Record Best Week Since August — SPCX, NVDA, ARM, AZN In Focus
Investing.com
·
7 hours ago
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.10%
Profile
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
About Evogene Ltd
CEOOfer Haviv
Employees52
Founded2002
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteevogene.com